Multi-stakeholder workshop on Pharmacogenomics

The European Commission, the Heads of Medicines Agencies and the EMA are organising a multi-stakeholder hybrid workshop on Pharmacogenomics at EMA.

The objectives of the workshop are to:

• identify priority areas for additional regulatory action to promote the clinical implementation of pharmacogenomics;
• discuss how medicines regulators can facilitate the uptake of genomics by national healthcare systems;
• discuss how to leverage genomic data linked to real-world data sources with examples of current studies using such data;
• discuss how to increase the regulatory impact of EU-funded projects in personalised medicine.

The outcome of the workshop will inform a roadmap towards the clinical implementation of pharmacogenomics in Europe.

More information for the event can be read here.

Virtual participation to the event is open to all stakeholders. Prior registration before 13th of September is required via this link.